CompletedNCT01689909
Zolpidem or Placebo for Insomnia and Suicidal Thoughts in Depression
About this title
Read the official source — NCT01689909Medication studyAges 18–65United StatesSuicide prevention
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Augusta and 3 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: December 6, 2012
- Recruitment status
- Completed
- Enrollment listed in the registry
- 103
- Sponsor
- Augusta University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01689909
- Official title
Show the full official title
Reducing Suicidal Ideation Through Insomnia Treatment
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Augusta · Durham · Wake Forest
1 more locations
- Madison
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Augusta University, a university.
Did this study involve medication?
Yes. The study involved medication, including Zolpidem-CR and Placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
